This will help pick up that wider audience that this stock needs. I can't see how some investors wouldn't be real comfortable buying this up to $16. I would also think the company could be swallowed up by one of the giant pharma companies soon, if they want to go in that direction.

It was really good to see that blog on the 15th confirming our assessment. You start to feel like you must be missing something when the stock doesn't go up right away, but I believe those who are patient with this will be richly rewarded.